img

Global TB Vaccine Treatment Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global TB Vaccine Treatment Market Insights, Forecast to 2034

TB Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
Global TB Vaccine Treatment market is expected to reach to US$ 74 million in 2024, with a positive growth of %, compared with US$ 72 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, TB Vaccine Treatment industry is evaluated to reach US$ 88 million in 2029. The CAGR will be 2.9% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global TB Vaccine Treatment market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global TB Vaccine Treatment market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Segment by Type
Immune Vaccine
Therapy Vaccine

Segment by Application


Self-Procurement
UNICEF
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ TB Vaccine Treatment plant distribution, commercial date of TB Vaccine Treatment, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, TB Vaccine Treatment introduction, etc. TB Vaccine Treatment Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of TB Vaccine Treatment
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 TB Vaccine Treatment Product Introduction
1.2 Market by Type
1.2.1 Global TB Vaccine Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 Market by Application
1.3.1 Global TB Vaccine Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global TB Vaccine Treatment Sales Estimates and Forecasts 2018-2029
2.2 Global TB Vaccine Treatment Revenue by Region
2.2.1 Global TB Vaccine Treatment Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global TB Vaccine Treatment Revenue by Region (2018-2024)
2.2.3 Global TB Vaccine Treatment Revenue by Region (2024-2029)
2.2.4 Global TB Vaccine Treatment Revenue Market Share by Region (2018-2029)
2.3 Global TB Vaccine Treatment Sales Estimates and Forecasts 2018-2029
2.4 Global TB Vaccine Treatment Sales by Region
2.4.1 Global TB Vaccine Treatment Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global TB Vaccine Treatment Sales by Region (2018-2024)
2.4.3 Global TB Vaccine Treatment Sales by Region (2024-2029)
2.4.4 Global TB Vaccine Treatment Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global TB Vaccine Treatment Sales by Manufacturers
3.1.1 Global TB Vaccine Treatment Sales by Manufacturers (2018-2024)
3.1.2 Global TB Vaccine Treatment Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of TB Vaccine Treatment in 2022
3.2 Global TB Vaccine Treatment Revenue by Manufacturers
3.2.1 Global TB Vaccine Treatment Revenue by Manufacturers (2018-2024)
3.2.2 Global TB Vaccine Treatment Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by TB Vaccine Treatment Revenue in 2022
3.3 Global Key Players of TB Vaccine Treatment, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global TB Vaccine Treatment Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global TB Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of TB Vaccine Treatment, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of TB Vaccine Treatment, Product Offered and Application
3.8 Global Key Manufacturers of TB Vaccine Treatment, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global TB Vaccine Treatment Sales by Type
4.1.1 Global TB Vaccine Treatment Historical Sales by Type (2018-2024)
4.1.2 Global TB Vaccine Treatment Forecasted Sales by Type (2024-2029)
4.1.3 Global TB Vaccine Treatment Sales Market Share by Type (2018-2029)
4.2 Global TB Vaccine Treatment Revenue by Type
4.2.1 Global TB Vaccine Treatment Historical Revenue by Type (2018-2024)
4.2.2 Global TB Vaccine Treatment Forecasted Revenue by Type (2024-2029)
4.2.3 Global TB Vaccine Treatment Revenue Market Share by Type (2018-2029)
4.3 Global TB Vaccine Treatment Price by Type
4.3.1 Global TB Vaccine Treatment Price by Type (2018-2024)
4.3.2 Global TB Vaccine Treatment Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global TB Vaccine Treatment Sales by Application
5.1.1 Global TB Vaccine Treatment Historical Sales by Application (2018-2024)
5.1.2 Global TB Vaccine Treatment Forecasted Sales by Application (2024-2029)
5.1.3 Global TB Vaccine Treatment Sales Market Share by Application (2018-2029)
5.2 Global TB Vaccine Treatment Revenue by Application
5.2.1 Global TB Vaccine Treatment Historical Revenue by Application (2018-2024)
5.2.2 Global TB Vaccine Treatment Forecasted Revenue by Application (2024-2029)
5.2.3 Global TB Vaccine Treatment Revenue Market Share by Application (2018-2029)
5.3 Global TB Vaccine Treatment Price by Application
5.3.1 Global TB Vaccine Treatment Price by Application (2018-2024)
5.3.2 Global TB Vaccine Treatment Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada TB Vaccine Treatment Market Size by Type
6.1.1 US & Canada TB Vaccine Treatment Sales by Type (2018-2029)
6.1.2 US & Canada TB Vaccine Treatment Revenue by Type (2018-2029)
6.2 US & Canada TB Vaccine Treatment Market Size by Application
6.2.1 US & Canada TB Vaccine Treatment Sales by Application (2018-2029)
6.2.2 US & Canada TB Vaccine Treatment Revenue by Application (2018-2029)
6.3 US & Canada TB Vaccine Treatment Market Size by Country
6.3.1 US & Canada TB Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada TB Vaccine Treatment Sales by Country (2018-2029)
6.3.3 US & Canada TB Vaccine Treatment Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe TB Vaccine Treatment Market Size by Type
7.1.1 Europe TB Vaccine Treatment Sales by Type (2018-2029)
7.1.2 Europe TB Vaccine Treatment Revenue by Type (2018-2029)
7.2 Europe TB Vaccine Treatment Market Size by Application
7.2.1 Europe TB Vaccine Treatment Sales by Application (2018-2029)
7.2.2 Europe TB Vaccine Treatment Revenue by Application (2018-2029)
7.3 Europe TB Vaccine Treatment Market Size by Country
7.3.1 Europe TB Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe TB Vaccine Treatment Sales by Country (2018-2029)
7.3.3 Europe TB Vaccine Treatment Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China TB Vaccine Treatment Market Size
8.1.1 China TB Vaccine Treatment Sales (2018-2029)
8.1.2 China TB Vaccine Treatment Revenue (2018-2029)
8.2 China TB Vaccine Treatment Market Size by Application
8.2.1 China TB Vaccine Treatment Sales by Application (2018-2029)
8.2.2 China TB Vaccine Treatment Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia TB Vaccine Treatment Market Size by Type
9.1.1 Asia TB Vaccine Treatment Sales by Type (2018-2029)
9.1.2 Asia TB Vaccine Treatment Revenue by Type (2018-2029)
9.2 Asia TB Vaccine Treatment Market Size by Application
9.2.1 Asia TB Vaccine Treatment Sales by Application (2018-2029)
9.2.2 Asia TB Vaccine Treatment Revenue by Application (2018-2029)
9.3 Asia TB Vaccine Treatment Sales by Region
9.3.1 Asia TB Vaccine Treatment Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia TB Vaccine Treatment Revenue by Region (2018-2029)
9.3.3 Asia TB Vaccine Treatment Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America TB Vaccine Treatment Market Size by Type
10.1.1 Middle East, Africa and Latin America TB Vaccine Treatment Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America TB Vaccine Treatment Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America TB Vaccine Treatment Market Size by Application
10.2.1 Middle East, Africa and Latin America TB Vaccine Treatment Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America TB Vaccine Treatment Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America TB Vaccine Treatment Sales by Country
10.3.1 Middle East, Africa and Latin America TB Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America TB Vaccine Treatment Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America TB Vaccine Treatment Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck TB Vaccine Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Merck TB Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Japan BCG Lab
11.2.1 Japan BCG Lab Company Information
11.2.2 Japan BCG Lab Overview
11.2.3 Japan BCG Lab TB Vaccine Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Japan BCG Lab TB Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Japan BCG Lab Recent Developments
11.3 Serum Institute of India
11.3.1 Serum Institute of India Company Information
11.3.2 Serum Institute of India Overview
11.3.3 Serum Institute of India TB Vaccine Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Serum Institute of India TB Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Serum Institute of India Recent Developments
11.4 AJ Vaccines
11.4.1 AJ Vaccines Company Information
11.4.2 AJ Vaccines Overview
11.4.3 AJ Vaccines TB Vaccine Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 AJ Vaccines TB Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AJ Vaccines Recent Developments
11.5 BioFarma
11.5.1 BioFarma Company Information
11.5.2 BioFarma Overview
11.5.3 BioFarma TB Vaccine Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 BioFarma TB Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 BioFarma Recent Developments
11.6 GreenSignal Bio Pharma
11.6.1 GreenSignal Bio Pharma Company Information
11.6.2 GreenSignal Bio Pharma Overview
11.6.3 GreenSignal Bio Pharma TB Vaccine Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 GreenSignal Bio Pharma TB Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GreenSignal Bio Pharma Recent Developments
11.7 China National Biotec
11.7.1 China National Biotec Company Information
11.7.2 China National Biotec Overview
11.7.3 China National Biotec TB Vaccine Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 China National Biotec TB Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 China National Biotec Recent Developments
11.8 Biomed Lublin
11.8.1 Biomed Lublin Company Information
11.8.2 Biomed Lublin Overview
11.8.3 Biomed Lublin TB Vaccine Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Biomed Lublin TB Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Biomed Lublin Recent Developments
11.9 Taj Pharmaceuticals
11.9.1 Taj Pharmaceuticals Company Information
11.9.2 Taj Pharmaceuticals Overview
11.9.3 Taj Pharmaceuticals TB Vaccine Treatment Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Taj Pharmaceuticals TB Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Taj Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 TB Vaccine Treatment Industry Chain Analysis
12.2 TB Vaccine Treatment Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 TB Vaccine Treatment Production Mode & Process
12.4 TB Vaccine Treatment Sales and Marketing
12.4.1 TB Vaccine Treatment Sales Channels
12.4.2 TB Vaccine Treatment Distributors
12.5 TB Vaccine Treatment Customers
13 Market Dynamics
13.1 TB Vaccine Treatment Industry Trends
13.2 TB Vaccine Treatment Market Drivers
13.3 TB Vaccine Treatment Market Challenges
13.4 TB Vaccine Treatment Market Restraints
14 Key Findings in The Global TB Vaccine Treatment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global TB Vaccine Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Immune Vaccine
Table 3. Major Manufacturers of Therapy Vaccine
Table 4. Global TB Vaccine Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global TB Vaccine Treatment Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global TB Vaccine Treatment Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global TB Vaccine Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global TB Vaccine Treatment Revenue Market Share by Region (2018-2024)
Table 9. Global TB Vaccine Treatment Revenue Market Share by Region (2024-2029)
Table 10. Global TB Vaccine Treatment Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global TB Vaccine Treatment Sales by Region (2018-2024) & (K Dose)
Table 12. Global TB Vaccine Treatment Sales by Region (2024-2029) & (K Dose)
Table 13. Global TB Vaccine Treatment Sales Market Share by Region (2018-2024)
Table 14. Global TB Vaccine Treatment Sales Market Share by Region (2024-2029)
Table 15. Global TB Vaccine Treatment Sales by Manufacturers (2018-2024) & (K Dose)
Table 16. Global TB Vaccine Treatment Sales Share by Manufacturers (2018-2024)
Table 17. Global TB Vaccine Treatment Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global TB Vaccine Treatment Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of TB Vaccine Treatment, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. TB Vaccine Treatment Price by Manufacturers 2018-2024 (US$/K Dose)
Table 21. Global TB Vaccine Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global TB Vaccine Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TB Vaccine Treatment as of 2022)
Table 23. Global Key Manufacturers of TB Vaccine Treatment, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of TB Vaccine Treatment, Product Offered and Application
Table 25. Global Key Manufacturers of TB Vaccine Treatment, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global TB Vaccine Treatment Sales by Type (2018-2024) & (K Dose)
Table 28. Global TB Vaccine Treatment Sales by Type (2024-2029) & (K Dose)
Table 29. Global TB Vaccine Treatment Sales Share by Type (2018-2024)
Table 30. Global TB Vaccine Treatment Sales Share by Type (2024-2029)
Table 31. Global TB Vaccine Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global TB Vaccine Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global TB Vaccine Treatment Revenue Share by Type (2018-2024)
Table 34. Global TB Vaccine Treatment Revenue Share by Type (2024-2029)
Table 35. TB Vaccine Treatment Price by Type (2018-2024) & (US$/K Dose)
Table 36. Global TB Vaccine Treatment Price Forecast by Type (2024-2029) & (US$/K Dose)
Table 37. Global TB Vaccine Treatment Sales by Application (2018-2024) & (K Dose)
Table 38. Global TB Vaccine Treatment Sales by Application (2024-2029) & (K Dose)
Table 39. Global TB Vaccine Treatment Sales Share by Application (2018-2024)
Table 40. Global TB Vaccine Treatment Sales Share by Application (2024-2029)
Table 41. Global TB Vaccine Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global TB Vaccine Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global TB Vaccine Treatment Revenue Share by Application (2018-2024)
Table 44. Global TB Vaccine Treatment Revenue Share by Application (2024-2029)
Table 45. TB Vaccine Treatment Price by Application (2018-2024) & (US$/K Dose)
Table 46. Global TB Vaccine Treatment Price Forecast by Application (2024-2029) & (US$/K Dose)
Table 47. US & Canada TB Vaccine Treatment Sales by Type (2018-2024) & (K Dose)
Table 48. US & Canada TB Vaccine Treatment Sales by Type (2024-2029) & (K Dose)
Table 49. US & Canada TB Vaccine Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada TB Vaccine Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada TB Vaccine Treatment Sales by Application (2018-2024) & (K Dose)
Table 52. US & Canada TB Vaccine Treatment Sales by Application (2024-2029) & (K Dose)
Table 53. US & Canada TB Vaccine Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada TB Vaccine Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada TB Vaccine Treatment Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada TB Vaccine Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada TB Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada TB Vaccine Treatment Sales by Country (2018-2024) & (K Dose)
Table 59. US & Canada TB Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 60. Europe TB Vaccine Treatment Sales by Type (2018-2024) & (K Dose)
Table 61. Europe TB Vaccine Treatment Sales by Type (2024-2029) & (K Dose)
Table 62. Europe TB Vaccine Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe TB Vaccine Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe TB Vaccine Treatment Sales by Application (2018-2024) & (K Dose)
Table 65. Europe TB Vaccine Treatment Sales by Application (2024-2029) & (K Dose)
Table 66. Europe TB Vaccine Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe TB Vaccine Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe TB Vaccine Treatment Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe TB Vaccine Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe TB Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe TB Vaccine Treatment Sales by Country (2018-2024) & (K Dose)
Table 72. Europe TB Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 73. China TB Vaccine Treatment Sales by Type (2018-2024) & (K Dose)
Table 74. China TB Vaccine Treatment Sales by Type (2024-2029) & (K Dose)
Table 75. China TB Vaccine Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 76. China TB Vaccine Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 77. China TB Vaccine Treatment Sales by Application (2018-2024) & (K Dose)
Table 78. China TB Vaccine Treatment Sales by Application (2024-2029) & (K Dose)
Table 79. China TB Vaccine Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 80. China TB Vaccine Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia TB Vaccine Treatment Sales by Type (2018-2024) & (K Dose)
Table 82. Asia TB Vaccine Treatment Sales by Type (2024-2029) & (K Dose)
Table 83. Asia TB Vaccine Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia TB Vaccine Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia TB Vaccine Treatment Sales by Application (2018-2024) & (K Dose)
Table 86. Asia TB Vaccine Treatment Sales by Application (2024-2029) & (K Dose)
Table 87. Asia TB Vaccine Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia TB Vaccine Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia TB Vaccine Treatment Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia TB Vaccine Treatment Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia TB Vaccine Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia TB Vaccine Treatment Sales by Region (2018-2024) & (K Dose)
Table 93. Asia TB Vaccine Treatment Sales by Region (2024-2029) & (K Dose)
Table 94. Middle East, Africa and Latin America TB Vaccine Treatment Sales by Type (2018-2024) & (K Dose)
Table 95. Middle East, Africa and Latin America TB Vaccine Treatment Sales by Type (2024-2029) & (K Dose)
Table 96. Middle East, Africa and Latin America TB Vaccine Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America TB Vaccine Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America TB Vaccine Treatment Sales by Application (2018-2024) & (K Dose)
Table 99. Middle East, Africa and Latin America TB Vaccine Treatment Sales by Application (2024-2029) & (K Dose)
Table 100. Middle East, Africa and Latin America TB Vaccine Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America TB Vaccine Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America TB Vaccine Treatment Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America TB Vaccine Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America TB Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America TB Vaccine Treatment Sales by Country (2018-2024) & (K Dose)
Table 106. Middle East, Africa and Latin America TB Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 107. Merck Company Information
Table 108. Merck Description and Major Businesses
Table 109. Merck TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2024)
Table 110. Merck TB Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Merck Recent Developments
Table 112. Japan BCG Lab Company Information
Table 113. Japan BCG Lab Description and Major Businesses
Table 114. Japan BCG Lab TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2024)
Table 115. Japan BCG Lab TB Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Japan BCG Lab Recent Developments
Table 117. Serum Institute of India Company Information
Table 118. Serum Institute of India Description and Major Businesses
Table 119. Serum Institute of India TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2024)
Table 120. Serum Institute of India TB Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Serum Institute of India Recent Developments
Table 122. AJ Vaccines Company Information
Table 123. AJ Vaccines Description and Major Businesses
Table 124. AJ Vaccines TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2024)
Table 125. AJ Vaccines TB Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. AJ Vaccines Recent Developments
Table 127. BioFarma Company Information
Table 128. BioFarma Description and Major Businesses
Table 129. BioFarma TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2024)
Table 130. BioFarma TB Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. BioFarma Recent Developments
Table 132. GreenSignal Bio Pharma Company Information
Table 133. GreenSignal Bio Pharma Description and Major Businesses
Table 134. GreenSignal Bio Pharma TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2024)
Table 135. GreenSignal Bio Pharma TB Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. GreenSignal Bio Pharma Recent Developments
Table 137. China National Biotec Company Information
Table 138. China National Biotec Description and Major Businesses
Table 139. China National Biotec TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2024)
Table 140. China National Biotec TB Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. China National Biotec Recent Developments
Table 142. Biomed Lublin Company Information
Table 143. Biomed Lublin Description and Major Businesses
Table 144. Biomed Lublin TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2024)
Table 145. Biomed Lublin TB Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Biomed Lublin Recent Developments
Table 147. Taj Pharmaceuticals Company Information
Table 148. Taj Pharmaceuticals Description and Major Businesses
Table 149. Taj Pharmaceuticals TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2024)
Table 150. Taj Pharmaceuticals TB Vaccine Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Taj Pharmaceuticals Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. TB Vaccine Treatment Distributors List
Table 155. TB Vaccine Treatment Customers List
Table 156. TB Vaccine Treatment Market Trends
Table 157. TB Vaccine Treatment Market Drivers
Table 158. TB Vaccine Treatment Market Challenges
Table 159. TB Vaccine Treatment Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. TB Vaccine Treatment Product Picture
Figure 2. Global TB Vaccine Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global TB Vaccine Treatment Market Share by Type in 2022 & 2029
Figure 4. Immune Vaccine Product Picture
Figure 5. Therapy Vaccine Product Picture
Figure 6. Global TB Vaccine Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global TB Vaccine Treatment Market Share by Application in 2022 & 2029
Figure 8. Self-Procurement
Figure 9. UNICEF
Figure 10. Other
Figure 11. TB Vaccine Treatment Report Years Considered
Figure 12. Global TB Vaccine Treatment Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global TB Vaccine Treatment Revenue 2018-2029 (US$ Million)
Figure 14. Global TB Vaccine Treatment Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global TB Vaccine Treatment Revenue Market Share by Region (2018-2029)
Figure 16. Global TB Vaccine Treatment Sales 2018-2029 ((K Dose)
Figure 17. Global TB Vaccine Treatment Sales Market Share by Region (2018-2029)
Figure 18. US & Canada TB Vaccine Treatment Sales YoY (2018-2029) & (K Dose)
Figure 19. US & Canada TB Vaccine Treatment Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe TB Vaccine Treatment Sales YoY (2018-2029) & (K Dose)
Figure 21. Europe TB Vaccine Treatment Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China TB Vaccine Treatment Sales YoY (2018-2029) & (K Dose)
Figure 23. China TB Vaccine Treatment Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) TB Vaccine Treatment Sales YoY (2018-2029) & (K Dose)
Figure 25. Asia (excluding China) TB Vaccine Treatment Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America TB Vaccine Treatment Sales YoY (2018-2029) & (K Dose)
Figure 27. Middle East, Africa and Latin America TB Vaccine Treatment Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The TB Vaccine Treatment Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of TB Vaccine Treatment in the World: Market Share by TB Vaccine Treatment Revenue in 2022
Figure 30. Global TB Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global TB Vaccine Treatment Sales Market Share by Type (2018-2029)
Figure 32. Global TB Vaccine Treatment Revenue Market Share by Type (2018-2029)
Figure 33. Global TB Vaccine Treatment Sales Market Share by Application (2018-2029)
Figure 34. Global TB Vaccine Treatment Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada TB Vaccine Treatment Sales Market Share by Type (2018-2029)
Figure 36. US & Canada TB Vaccine Treatment Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada TB Vaccine Treatment Sales Market Share by Application (2018-2029)
Figure 38. US & Canada TB Vaccine Treatment Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada TB Vaccine Treatment Revenue Share by Country (2018-2029)
Figure 40. US & Canada TB Vaccine Treatment Sales Share by Country (2018-2029)
Figure 41. U.S. TB Vaccine Treatment Revenue (2018-2029) & (US$ Million)
Figure 42. Canada TB Vaccine Treatment Revenue (2018-2029) & (US$ Million)
Figure 43. Europe TB Vaccine Treatment Sales Market Share by Type (2018-2029)
Figure 44. Europe TB Vaccine Treatment Revenue Market Share by Type (2018-2029)
Figure 45. Europe TB Vaccine Treatment Sales Market Share by Application (2018-2029)
Figure 46. Europe TB Vaccine Treatment Revenue Market Share by Application (2018-2029)
Figure 47. Europe TB Vaccine Treatment Revenue Share by Country (2018-2029)
Figure 48. Europe TB Vaccine Treatment Sales Share by Country (2018-2029)
Figure 49. Germany TB Vaccine Treatment Revenue (2018-2029) & (US$ Million)
Figure 50. France TB Vaccine Treatment Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. TB Vaccine Treatment Revenue (2018-2029) & (US$ Million)
Figure 52. Italy TB Vaccine Treatment Revenue (2018-2029) & (US$ Million)
Figure 53. Russia TB Vaccine Treatment Revenue (2018-2029) & (US$ Million)
Figure 54. China TB Vaccine Treatment Sales Market Share by Type (2018-2029)
Figure 55. China TB Vaccine Treatment Revenue Market Share by Type (2018-2029)
Figure 56. China TB Vaccine Treatment Sales Market Share by Application (2018-2029)
Figure 57. China TB Vaccine Treatment Revenue Market Share by Application (2018-2029)
Figure 58. Asia TB Vaccine Treatment Sales Market Share by Type (2018-2029)
Figure 59. Asia TB Vaccine Treatment Revenue Market Share by Type (2018-2029)
Figure 60. Asia TB Vaccine Treatment Sales Market Share by Application (2018-2029)
Figure 61. Asia TB Vaccine Treatment Revenue Market Share by Application (2018-2029)
Figure 62. Asia TB Vaccine Treatment Revenue Share by Region (2018-2029)
Figure 63. Asia TB Vaccine Treatment Sales Share by Region (2018-2029)
Figure 64. Japan TB Vaccine Treatment Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea TB Vaccine Treatment Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan TB Vaccine Treatment Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia TB Vaccine Treatment Revenue (2018-2029) & (US$ Million)
Figure 68. India TB Vaccine Treatment Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America TB Vaccine Treatment Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America TB Vaccine Treatment Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America TB Vaccine Treatment Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America TB Vaccine Treatment Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America TB Vaccine Treatment Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America TB Vaccine Treatment Sales Share by Country (2018-2029)
Figure 75. Brazil TB Vaccine Treatment Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico TB Vaccine Treatment Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey TB Vaccine Treatment Revenue (2018-2029) & (US$ Million)
Figure 78. Israel TB Vaccine Treatment Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries TB Vaccine Treatment Revenue (2018-2029) & (US$ Million)
Figure 80. TB Vaccine Treatment Value Chain
Figure 81. TB Vaccine Treatment Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries